Clinical trial
Randomized Controlled Study to Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
NCT01898923 is registered in ClinicalTrials.gov with Oneness Biotech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Study to Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
- Lead sponsor
- Oneness Biotech Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 23, 2012
- Completion date
- May 11, 2020
- Enrollment
- 236 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.